A large-scale observational study of chronic kidney disease (CKD) is due to launch in general practices this month, involving 3,205 Oxfordshire residents and led by Oxford University researchers.
Today, the National Kidney Foundation (NKF) has reached a scientific seminar with the Food and Drug Administration (FDA) and the European Medicines Agency (EMA)
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.